Search Results

Containing any of the words

Only of the type

Dr. Adelheid Schneider Speakers

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination with Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer. Drug Clinical Trial

An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% Of Tumor Cel Expressing Pd-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer. Drug Clinical Trial

The SFDA Will Sponsor One of The Panel Discussions:The 4th Conference on Food and Nutrition Takes Place Next Sunday News

SFDA Welcomes Submissions for the 5th Regulatory Research Day 2025 News

(SG-1802-04-H) Urgent Recall of (Mesh Products) Restorelle DirectFix Manufactured by Coloplast Medical Report

(SG-2106-335-H) Power Board Failures due to Component Electrical Overstress Medical Report

Saudi Food and Drug Authority (SFDA) PRESS RELEASE- Safety of Diane 35® and Risk of Thromboembolism News

(SG-1907-81-H) ElectroMist - Potential for failed stability antimicrobial effectiveness testing Medical Report

SFDA Captures 45 Pharmacies Selling Violating Products News